Is KYNB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KYNB. It does not provide personalized investment advice.

KYNB (Kyntra Bio, Inc. Common Stock) Stock Analysis - Financials

Kyntra Bio, Inc. Common Stock (KYNB) is a publicly traded the market company. As of October 1, 2026, KYNB trades at $6.89 with a market cap of $27.49M and a P/E ratio of 2.26. KYNB moved +3.59% today. Year to date, KYNB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $6.32 to $9.70. Analyst consensus is strong buy with an average price target of $39.67. Rallies surfaces KYNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are KYNB's key financials?

KYNB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KYNB recently traded at $6.89. Market cap is $27.49M. P/E ratio is 2.26. Revenue is $-1.47M.

KYNB Key Metrics

Key financial metrics for KYNB
Metric	Value
Price	$6.89
Market Cap	$27.49M
P/E Ratio	2.26
EPS	$2.96
Dividend Yield	0.00%
52-Week High	$9.70
52-Week Low	$6.32
Volume	13
Avg Volume	0
Revenue (TTM)	$-1.47M
Net Income	$11.97M
Gross Margin	100.14%

KYNB Analyst Consensus

4 analysts cover KYNB: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.67.

Common questions about KYNB

What are KYNB's key financials?: KYNB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KYNB recently traded at $6.89. Market cap is $27.49M. P/E ratio is 2.26. Revenue is $-1.47M.
Is KYNB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KYNB. It does not provide personalized investment advice.